Angiopoietins and Tie2 in vascular inflammation.
Angiopoietins and Tie2 in vascular inflammation.
复制标题
血管炎的血管蛋白和TIE2在血管炎症中。
DOI:
10.1097/moh.0000000000000361
复制
发表时间:
2017-09
影响因子:
3.2
通讯作者:
Parikh SM
中科院分区:
文献类型:
--
作者:
Parikh SM
As a subset of the organism-wide reaction to severe infection, the host vascular response has received increasing attention in recent years. The transformation that small blood vessels undergo to facilitate the clearance of pathogens may become harmful to the host if it occurs too broadly or if it is sustained too long. Adverse clinical manifestations of leaky and inflamed blood vessels include edema impairing the function of critical organs and circulatory shock. suggest that this host vascular response may be both measurable and potentially targetable. Tie2 is a receptor tyrosine kinase heavily enriched in the vascular endothelium whose tonic signaling actively maintains vascular quiescence. When Tie2 becomes inactivated, important molecular brakes are released in the endothelium that in turn, potentiate inflammation and vascular leakage. The ligands of Tie2, Angiopoietin-1 and -2, regulate its activation status. Genetic and molecular studies spanning thousands of human subjects link Tie2 and imbalance of the Angiopoietins to major adverse clinical events arising from bacterial sepsis, other severe infections, and even acute sterile inflammation. The Tie2 signaling axis may constitute a molecular switch in systemic inflammation that can be measured and manipulated to target the host vascular response therapeutically.